ea0026p679 | Diabetes therapy | ECE2011
Felechosa M Dieguez
, Rovira C Tuson
, Ragnarsson C Sanchez
, Alemany E Suarez-LLedo
, Garcia L Cacho
, Gallego N Valdes
, Santiago J Prieto
Aim: To assess the effectiveness, safety and tolerability of Exenatide twice daily treatment of type 2 diabetes and obesity.Material and methods: Data analysis of obese type 2 diabetic patients initiated on Exenatide therapy in our Endocrine clinics who complete 1 year of treatment.Results: We included 42 patients, 30 women (71.4%) and 12 men (28.6%), mean (±S.D.) age 57±10 and 9±7 years diabetes evolu...